Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Elderly people with early-stage lung cancer might also benefit from stereotactic body radiation therapy (SBRT), finds a study of more than 1,000 patients. The study, “Stereotactic Body Radiation Therapy in ... Read more
A clinical trial exploring entinostat in combination with Merck’s Keytruda (pembrolizumab) in non-small cell lung cancer (NSCLC) patients who progressed despite checkpoint-blocking treatment, met the required response threshold to ... Read more
The American Society for Radiation Oncology (ASTRO) has released new guidelines for treating inoperable lung cancer patients with stereotactic body radiation therapy (SBRT). Based on evidence from numerous studies ... Read more
Seventy percent of patients with brain cancer that originated in the lungs responded to treatment with Tagrisso (osimertinib), according to a Phase 3 clinical trial. That compared with 31 percent ... Read more
Tagrisso (osimertinib) was more effective than chemotherapy in treating lung cancer patients whose disease had progressed on another treatment, according to a Phase 3 clinical trial. Patients who took ... Read more
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Takeda‘s Alunbrig (brigatinib) to treat ALK-positive metastatic non-small cell lung cancer (NSCLC) in patients who either progressed or could ... Read more
Sleep apnea, and the recurrent lack of oxygen that it causes, may promote lung cancer growth and the ability of the cancer to spread. Researchers found that occasional low-oxygen conditions make ... Read more